SEC Form 4 · accession 0001232524-17-000076
Jazz Pharmaceuticals plc · JAZZ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Karen J Wilson
Officer — SVP, Finance & PAO
Period of report
Mar 6, 2017
Accepted (ET)
Mar 8, 2017 · 5:47 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001232524
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Mar 6, 2017 | F | 563 | $132.81 | D | 18,762 | D | |
| Ordinary Shares | Mar 8, 2017 | M | 2,896 | $46.83 | A | 21,658 | D | |
| Ordinary Shares | Mar 8, 2017 | M | 750 | $59.13 | A | 22,408 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock Option (right to buy)F2 | $46.83 | Mar 8, 2017 | M | 2,896 | D | — | Aug 8, 2022 | Ordinary Shares | 2,896 | 0 | D |
| Incentive Stock Option (right to buy)F3 | $59.13 | Mar 8, 2017 | M | 750 | D | — | Mar 4, 2023 | Ordinary Shares | 750 | 0 | D |
Explanation of responses
- F1Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units.
- F2This option was granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to this option vested over four years measured from the grant date, August 9, 2012, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter.
- F3This option was granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to this option vested over four years measured from the grant date, March 5, 2013, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter.